Final results of a Spanish Lung Cancer Group (SLCG) phase II study of paclitaxel (PAC) plus gemcitabine (GEM) in locally advanced and metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Isla, D [1 ]
González-Larriba, JL [1 ]
Felip, E [1 ]
Camps, C [1 ]
Artal, A [1 ]
Carrato, A [1 ]
Azagra, P [1 ]
Alberola, V [1 ]
Massutti, B [1 ]
Rosell, R [1 ]
机构：
[1] Hosp Clin Lozano Blesa, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
521P
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [31] Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience
    Kim, JH
    Kim, SY
    Jung, KH
    Park, K
    Suh, CW
    Lim, HY
    Kim, YH
    Ryoo, BY
    Cho, EK
    Park, BJ
    Heo, DS
    LUNG CANCER, 2006, 52 (01) : 75 - 81
  • [32] Phase mi study of Gemcitabine plus vinorelbine in non-small cell lung cancer (NSCLC)
    Puertas, J
    Esteban, E
    Fra, J
    Liano, JLG
    Vieitez, JM
    Estrada, E
    Palacio, I
    Muniz, I
    Buesa, JM
    Lacave, AJ
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [33] ACTIVITY OF PATUPILONE IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Zatloukal, P.
    Mellemgaard, A.
    Sanchez, J. M.
    Perry, M. C.
    Hamm, J. T.
    Van Meerbeeck, J.
    DeLeo, J. J.
    Gao, B.
    Johri, A. R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [34] Sex differences in non-small cell lung cancer (NSCLC) patients (p) participating in Spanish Lung Cancer Group (SLCG) trials
    Isla, D.
    Felip, E.
    Garrido, P.
    Vinolas, N.
    Garcia-Campelo, R.
    Lianes, P.
    Bover, I.
    Terrasa, J.
    Sanchez, J. J.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
  • [36] Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer
    Leow, CH
    Liam, CK
    RESPIROLOGY, 2005, 10 (05) : 629 - 635
  • [37] Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC)
    Bousahba, A., Sr.
    Bereksi-Reguig, F.
    Seghier, F.
    Boukerche, A.
    Dali-Youcef, A.
    Djellali, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Combination chemotherapy with carboplatin(CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263
  • [39] Phase II study of weekly gemcitabine in advanced non-small cell lung cancer
    Halme, M
    Jekunen, A
    Tamminen, K
    Mattson, K
    RESPIRATORY MEDICINE, 1997, 91 (07) : 423 - 426
  • [40] A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC) - A hoosier oncology group study
    Ng, EW
    Sandler, AB
    Robinson, L
    Einhorn, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 550 - 553
12345